Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary
Resource Information
The work Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary represents a distinct intellectual or artistic creation found in University of Missouri-St. Louis Libraries. This resource is a combination of several types including: Work, Language Material, Books.
The Resource
Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary
Resource Information
The work Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary represents a distinct intellectual or artistic creation found in University of Missouri-St. Louis Libraries. This resource is a combination of several types including: Work, Language Material, Books.
- Label
- Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary
- Title remainder
- establishing an agenda for 2020 : workshop summary
- Statement of responsibility
- Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
- Subject
-
- Business and medicine -- United States -- Congresses
- Clinical Trials as Topic
- Clinical trials -- Economic aspects -- United States -- Congresses
- Clinical trials -- Social aspects -- United States -- Congresses
- Clinical trials -- United States -- Congresses
- Congress
- Drug Design
- Drug Industry
- Drug development -- United States -- Congresses
- Drugs -- Testing -- Congresses
- Pharmaceutical industry -- United States -- Congresses
- Randomized Controlled Trials as Topic
- United States
- Language
- eng
- Summary
- "There is growing recognition that the United States' clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions. With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, and Translation held a two-day workshop in November 2011, bringing together leaders in research and health care. The workshop focused on how to transform the CTE and discussed a vision to make the enterprise more efficient, effective, and fully integrated into the health care system. Key issue areas addressed at the workshop included: the development of a robust clinical trials workforce, the alignment of cultural and financial incentives for clinical trials, and the creation of a sustainable infrastructure to support a transformed CTE. This document summarizes the workshop"--Publisher's description
- Cataloging source
- IDEBK
- Illustrations
-
- illustrations
- charts
- Index
- no index present
- Literary form
- non fiction
- Nature of contents
-
- dictionaries
- bibliography
Context
Context of Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summaryWork of
No resources found
No enriched resources found
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.umsl.edu/resource/7ojrng2lEm0/" typeof="CreativeWork http://bibfra.me/vocab/lite/Work"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.umsl.edu/resource/7ojrng2lEm0/">Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.umsl.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.umsl.edu/">University of Missouri-St. Louis Libraries</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Work Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.umsl.edu/resource/7ojrng2lEm0/" typeof="CreativeWork http://bibfra.me/vocab/lite/Work"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.umsl.edu/resource/7ojrng2lEm0/">Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.umsl.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.umsl.edu/">University of Missouri-St. Louis Libraries</a></span></span></span></span></div>